Deinonychus
Bluelighter
- Joined
- Oct 20, 2012
- Messages
- 401
Don't we have a feedback thread for those ideas? I think we used to.
There's a link at the top of the forum near the PD index, a thread that's for suggestions to improve the forum. Sadly it is archived, so theres no posting permissions.
I realise that Big & Dandy Threads are often in several ways flawed, like people only talking about their own anticipation of a drug not yet in circulation or off-topic banter or indeed repeats of questions (literal FAQs), but such things are largely unavoidable especially if threads are merged at an early stage. Everyone is welcome to ask the questions that have not yet been posed.*
Researching a substance using B&D's is indeed a lot of digging, and it is hard to improve that, you must understand this. To clean this up threads need reorganisation which has been done a few times in the past and which - trust me - is a hell of a lot of work.
I think BnDs really shine in the initial period where a drug has just come out and there's still a lot of blank spaces in our understanding of how it works and so forth. It's certainly true that it can devolve for a period of time into people asking each other if anybody has yet seen it on the market/bought it/tried it, but when that initial period of time passes the resulting portion of a BnD thread is really useful. Reports start rolling in and between people posting links to reports in the TR subforum or posting their initial impressions in short, less than full trip report fashion, the thread operates as sort of a central information exchange, which has greater value than a bunch of separate threads because it seems to me that the amount of information that is exchanged and the quality of that information increases in a non-linear way as the number of people in the discussion increases. So a single BnD thread for a new drug with fifteen frequent posters would be more valuable than five threads with three participants, and so on.
I also realise that B&D's often get ignored by comparison.
Despite these flaws I think merging for the creation of an archive is valuable and it helped me in the past because I was willing to read through the crap to find the good stuff.
Sure, I also have taken the time to read through the threads, and there's definitely value in having a central thread, especially for a new drug as I mentioned above. For me personally I consider BnD threads something to be mined for information, a passive source of data rather than an active participatory thing where I would post.
Believe it or not, the practice of merging only threads that aren't on page 1 is something that I have recently suggested among our staff and I try to adhere to that guideline. That why I didn't merge yet but instead say "in due time" i.e. when it falls off the first page.
I believe you, it's a reasonable extension of the current official practice I think, and I'm glad to see that I'm not the only one who has thought about this. This isn't a major issue IMO one way or another, and there's doubtless a lot more pressing issues that need to be addressed in the limited amount of time that's available to mods as volunteers. But all the same I expect that a lot of the progress that BL has seen over its lifetime has been the accumulated result of small incremental changes in policy and practice rather than radical breaks with past tradition, and this sort of idea constitutes a form of that positive, incremental change.
Suggestions that don't necessarily have to be posed publicly can be sent in a PM to prevent threads from going off-topic all the time because you see a flaw.
I hardly think that this single instance of pointing out what I see as a flaw in the ordinary method of doing things constitutes dragging threads off-topic 'all the time'. The thread for making suggestions for improving the forum is archived and thus you can't post in it. Regardless, I'll keep the rest of my reply to the PM system, lest I continue to be such a great digressive danger to the on-topic relevance of the forum 8(
Last edited: